Caregroup Sight Solution Private Limited - Due diligence report

A 360° intelligence report on Caregroup Sight Solution: trust score, financial health, credit view, compliance, directors, growth and distre…

2020-01-01 Mumbai, Maharashtra Active Unlisted Active Compliant
View plans
CS Caregroup Sight Solution Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Caregroup Sight Solution — 360° Intelligence Report

Generated from MCA filings & public records
82/100
Trust Score
Low Risk

Caregroup Sight Solution is assessed as Low Risk with a Trust Score of 82/100. Caregroup Sight Solution is an active private limited indian non-government company incorporated in 2020, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 26 Jun 2026 from the latest processed filings. Caregroup Sight Solution Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
82/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
63/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
95/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
95/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
85/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 95/100 Low Risk
  • Liabilities ≈ 38% EBITDA - serviceable.
  • Moderate gearing (D/E 1.42).
  • Working-capital cover adequate.
  • Profitable - internal accruals available.
  • Externally credit-rated (A-).

Charges position: 3 open (72.25 cr) · 4 satisfied (61.27 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others6 48.0 cr
Hdfc Bank Limited1 48.0 cr
Compliance Score: 63/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
  • 4 auditor resignation(s) filed - latest: PARIKH AND MAJMUDAR on 2025-02-28.
  • Delayed payments to MSME suppliers disclosed (1 disclosure(s)).
  • 16 active GST registration(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 85/100
NameDIN / PANDesignationAppointedTenureDIN status
JAGRAT NATVAR DAVE 01234567 Director 01/04/2018 6 yrs Approved
PURNIMA JAGRAT DAVE 01234567 Director 01/04/2018 6 yrs Approved
KRUTI VINAYAKBHAI TRIVEDI 01234567 Director 01/04/2018 6 yrs Approved
VIPAN KUMAR DUGGAL 01234567 Director 01/04/2018 6 yrs Approved
SANJAY ARGAL 01234567 Director 01/04/2018 6 yrs Approved
MUNAVVAR HUSAIN 01234567 Director 01/04/2018 6 yrs Approved
PURNIMA JAGRAT DAVE 01234567 Director 01/04/2018 6 yrs Approved
Shrinali Harshit Patel 01234567 Director 01/04/2018 6 yrs Approved
Abhijit Bhagvat Patil 01234567 Director 01/04/2018 6 yrs Approved
Ketan Nagjibhai Kotharia 01234567 Director 01/04/2018 6 yrs Approved
  • 10 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2024)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2024 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
1
Group entities
1
Capital events
1 allotment(s) · 1 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Care4sight Pharma Private Limited Subsidiary Company 74.00%
Uk Implant Manufacturing Co. Ltd. Subsidiary Company 74.00%
Uk Implant Manufacturing Egypt Co. Subsidiary Company 74.00%

Key managerial personnel: JAGRAT NATVAR DAVE (Managing Director) · PURNIMA JAGRAT DAVE (CEO) · KRUTI VINAYAKBHAI TRIVEDI (CFO) · PURNIMA JAGRAT DAVE (CEO)

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 90
Growth signals & trust indicators
Revenue acceleration: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
EPFO headcount growing - hiring signal.
Operating for 6 years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
3 open charge(s) registered - assets are encumbered.
4 auditor resignation(s) on record - review the stated reasons.
MSME payment delays disclosed - latest outstanding 28,320.00.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence77/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment87/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 72.25 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view86/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 3 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
05 Nov 2025
Director appointed
Abhijit Bhagvat Patil (Director)
Director appointed
Ketan Nagjibhai Kotharia (Director)
20 Jan 2025
Director ceased
PURNIMA JAGRAT DAVE
16 Jan 2025
Last AGM held
Annual general meeting
31 Mar 2024
Share transfer (FY 2024)
18000000.00000000 shares to Purnima Jagrat Dave
Latest balance sheet
Filed with ROC
13 Dec 2023
Charge satisfied
Others
29 Nov 2023
Charge satisfied
Others
24 Nov 2023
Charge satisfied
Others
01 Jun 2023
Director appointed
PURNIMA JAGRAT DAVE (CEO)
Director appointed
KRUTI VINAYAKBHAI TRIVEDI (CFO)
30 Sep 2022
Director ceased
VIPAN KUMAR DUGGAL
Director ceased
SANJAY ARGAL
Director ceased
KETAN NAGJIBHAI KOTHARIA
Director ceased
MUNAVVAR HUSAIN
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - manageable leverage.
Net worth is positive.
10 active director(s) / partner(s); board looks stable and experienced.
16 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 1 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A- from Care.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2024 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Anmol Feeds U10803WB2001PTC093568 Howrah, West Bengal, India
Sahajanand Medical Technologies U33119GJ2001PLC040121 Surat, Gujarat, India
Automatworld U45201DL2005PTC139270 Delhi, Delhi, India
Punjab Retail Private Limited U36911MP1998PTC020496 Indore, Madhya Pradesh, India
Parishi Diamond Private Limited U36999MH2021PTC361036 Mumbai, Maharashtra, India
Torrecid U26915GJ2010FTC104703 Vadodara, Gujarat, India
Linc Pen & Plastics L36991WB1994PLC065583 Kolkata, West Bengal, India
Aries Agro L99999MH1969PLC014465 Mumbai-43, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Caregroup Sight Solution before audits and certifications: compliance score 63/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Caregroup Sight Solution: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 95/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Caregroup Sight Solution - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 82/100, distress signals and MSME payment-delay disclosures - know whether Caregroup Sight Solution pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Caregroup Sight Solution - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Caregroup Sight Solution an active company?

Caregroup Sight Solution has MCA status “Active” with a compliance score of 63/100 (Moderate).

Is Caregroup Sight Solution financially healthy?

Caregroup Sight Solution has a Financial Health Score of 95/100 (Low Risk) based on its filed financial statements.

Should I do business with Caregroup Sight Solution?

Its overall Trust Score is 82/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Caregroup Sight Solution?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 10 active director(s) are on record.

Does Caregroup Sight Solution have loans or charges against its assets?

3 open charge(s) are registered against its assets, and 4 earlier charge(s) stand satisfied.

Is Caregroup Sight Solution up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 63/100 (Moderate).

Is it risky to lend to Caregroup Sight Solution?

Its Credit Risk Score is 95/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.